Eureka Forbes (543482) Q4 21/22 earnings summary

Executive summary

• FY22 marked a transformation year: the Health, Hygiene, Safety Products and Services undertaking was acquired from Feb. 1, with FY results consequently not comparable YoY.

• Consolidated revenue from operations was ₹38,175.01 lakh, EBITDA ₹2,066.39 lakh, PBT ₹706.23 lakh and PAT ₹261.52 lakh.

• Multi-channel sales and service operations proved resilient through pandemic disruptions; e-commerce was the fastest-growing channel and service NPS improved.

Financial highlights

• Consolidated total revenue was ₹38,407.66 lakh vs ₹788.53 lakh in FY21; FY22 includes the acquired undertaking from Feb. 1, limiting comparability.

• Consolidated EBITDA was ₹2,066.39 lakh vs loss of ₹128.21 lakh; PBT ₹706.23 lakh vs loss of ₹162.24 lakh.

• Consolidated PAT was ₹261.52 lakh vs loss of ₹163.03 lakh; EPS was ₹0.72 vs loss per share of ₹3.38.

• Standalone revenue from operations was ₹38,100.13 lakh; EBITDA ₹2,021.50 lakh; PBT ₹689.52 lakh; PAT ₹280.30 lakh.

• The acquired business contributed ₹37,013.67 lakh revenue and ₹2,215.53 lakh EBITDA from Feb. 1 to Mar. 31; pro forma FY22 turnover was stated at ₹203,601.05 lakh.

Outlook and guidance

• Strategy centers on profitable growth in core water, cleaning and air categories, exiting unprofitable non-core activities and expanding reach in underpenetrated Tier 2 and 3 markets.

• Priorities include digital-first customer engagement, product innovation, portfolio expansion, stronger manufacturing, and service improvements.

• Management expects consumer durables demand to remain robust, with premium products, home convenience and rural demand supporting the market.